Related Experiment Video
Updated: Aug 5, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Does loxapine have "atypical" properties? Clinical evidence
1Department of Psychiatry, Harvard Medical School, and Massachusetts General Hospital, Menemsha. glazmedsol@aol.com
The Journal of Clinical Psychiatry
|May 26, 1999
Summary
Loxapine
Area of Science:
- Pharmacology
- Clinical Psychiatry
- Neuroscience
Background:
- Loxapine exhibits serotonin (5-HT2) and dopamine (D2) receptor binding affinities comparable to atypical antipsychotics.
- Existing research suggests potential clinical benefits of loxapine, particularly for negative symptoms and treatment-resistant conditions.
Purpose of the Study:
- To review clinical data and assess if loxapine's pharmacologic profile correlates with observed effects on patient symptoms and behaviors.
- To determine if loxapine can be classified as an atypical antipsychotic agent based on clinical evidence.
Main Methods:
- Review of existing clinical data and pharmacologic studies on loxapine.
- Analysis of loxapine's binding affinity for serotonin (5-HT2) and dopamine (D2) receptors.
- Evaluation of clinical outcomes related to negative symptoms and refractory states.
Main Results:
- Pharmacologic data indicate loxapine has a binding affinity profile similar to atypical antipsychotics.
- Clinical review suggests loxapine may offer benefits for negative symptoms and refractory states compared to typical antipsychotics.
Conclusions:
- Loxapine shows potential as a beneficial agent for negative symptoms and refractory states in antipsychotic treatment.
- Further controlled, fixed-dose studies using modern methodologies are necessary to definitively classify loxapine as an atypical antipsychotic agent.
Related Concept Videos
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications